<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04708951</url>
  </required_header>
  <id_info>
    <org_study_id>ENDOCUFF vs. G-EYE</org_study_id>
    <nct_id>NCT04708951</nct_id>
  </id_info>
  <brief_title>Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE®</brief_title>
  <official_title>A Prospective Randomized Comparison of Colonoscopy Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®) (Endocuff) Versus a Permanently Mounted Balloon (G-EYE®)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Horst Schmidt Klinik GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr. Horst Schmidt Klinik GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is intended to compare the detection rate obtained by performing G-EYE® high&#xD;
      definition colonoscopy vs. the detection rate obtained by performing ECV high definition&#xD;
      colonoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, two-arm, randomized, open-label study intended to compare the&#xD;
      detection rate obtained by performing G-EYE® high definition colonoscopy vs. the detection&#xD;
      rate obtained by performing ECV high definition colonoscopy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Actual">October 15, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects will be randomized to one of two groups - ECV colonoscopy or G-EYE® colonoscopy</intervention_model_description>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison between adenoma detection rate of G-EYE® colonoscopy and EndoCuff Vision®</measure>
    <time_frame>June 2021</time_frame>
    <description>G-EYE® colonoscopy adenoma detection rate will be compared to the adenoma detection rate of EndoCuff Vision® colonoscopy. The primary performance measure is the adenoma detection rate (ADR), which is defined as the percentage of subjects with at least one adenoma found, in each of the study groups.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">970</enrollment>
  <condition>Adenoma</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>ECV colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EndoCuff Vision® device (ECV)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G-EYE® colonoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>G-EYE® colonoscope (G-EYE)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ENDOCUFF VISION® device</intervention_name>
    <description>ENDOCUFF VISION® is a disposable cap placed on the tip of a standard colonoscope, intended to flatten colonic folds and assist in controlling the colonoscope's field of view and tip positioning</description>
    <arm_group_label>ECV colonoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>G-EYE® colonoscope</intervention_name>
    <description>The G-EYE® balloon is a reusable (reprocessable) balloon permanently installed on the distal tip of a standard colonoscope, and is also intended to assist in flattening colonic folds and control the colonoscope's field of view and tip positioning</description>
    <arm_group_label>G-EYE® colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Screening and surveillance population for Adenoma and CRC.&#xD;
&#xD;
          2. The patient must understand and sign a written informed consent for the procedure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects with inflammatory bowel disease;&#xD;
&#xD;
          2. Subjects with a personal history of hereditary polyposis syndrome;&#xD;
&#xD;
          3. Subjects with suspected chronic stricture potentially precluding complete colonoscopy;&#xD;
&#xD;
          4. Subjects with diverticulitis or toxic megacolon;&#xD;
&#xD;
          5. Subjects with prior colonic surgery (exclusion appendectomy)&#xD;
&#xD;
          6. Subjects with a history of radiation therapy to abdomen or pelvis;&#xD;
&#xD;
          7. Pregnant or lactating female subjects;&#xD;
&#xD;
          8. Subjects who are currently enrolled in another clinical investigation.&#xD;
&#xD;
          9. Subjects with current oral or parenteral use of anticoagulants, not considered&#xD;
             eligible by the investigator.&#xD;
&#xD;
         10. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)&#xD;
&#xD;
         11. Any patient condition deemed too risky for the study by the investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Kiesslich, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Dr. Horst Schmidt Kliniken Wiesbaden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IU Health University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Dr. Horst Schmidt Kliniken Wiesbaden</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr. Horst Schmidt Klinik GmbH</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Ralf Kiesslich</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Adenoma</keyword>
  <keyword>Colorectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

